Teva Pharmaceutical

Israeli authorities to demand $271M bill from tax-advantaged Teva: report
Israeli authorities to demand $271M bill from tax-advantaged Teva: report
Fierce Pharma
Teva Pharmaceutical
Israel
taxes
Flag link:
FDA Approves First Generic Version of Lundbeck’s Sabril
FDA Approves First Generic Version of Lundbeck’s Sabril
RAPS.org
FDA
Teva Pharmaceutical
Lundbeck
seizures
generics
Sabril
Vigabatrin
Flag link:
Teva hands over $135M to settle claims of inflated drug prices
Teva hands over $135M to settle claims of inflated drug prices
BioPharma Dive
Teva Pharmaceutical
drug pricing
Illinois
Flag link:
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Flag link:
Teva shells out $135M to wrap Illinois AG's Medicaid pricing fraud suit
Teva shells out $135M to wrap Illinois AG's Medicaid pricing fraud suit
Fierce Pharma
Teva Pharmaceutical
Medicaid
Illinois
drug pricing
Flag link:
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
Flag link:
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
GoinPharma
Teva Pharmaceutical
debt
JPMHC 2019
Kåre Schultz
Pharma CEOs
Flag link:
Teva and Neos settle over Cotempla patent dispute
Teva and Neos settle over Cotempla patent dispute
Pharmaforum
Teva Pharmaceutical
Neos Therapeutics
generics
patents
ADHD
Cotempla XR-ODT
Flag link:
FDA approves Teva’s digital COPD, asthma inhaler
FDA approves Teva’s digital COPD, asthma inhaler
Drug Delivery Business News
Teva Pharmaceutical
ProAir Digihaler
devices
asthma
COPD
FDA
Flag link:
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Pharmaceutical Business Review
Teva Pharmaceutical
migraines
clinical trials
fremanezumab
Flag link:
Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive
Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive
Fierce Pharma
Teva Pharmaceutical
Tel Aviv
Flag link:
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Flag link:
FDA approves first biosimilar for NHL
FDA approves first biosimilar for NHL
BioCentury
Celltrion
Teva Pharmaceutical
non-Hodgkin's lymphoma
Truxima
biosimilars
rituximab
Flag link:
Teva launches EpiPen generic at same price as Mylan's version
Teva launches EpiPen generic at same price as Mylan's version
Biopharma Dive
Teva Pharmaceutical
Mylan
EpiPens
generics
Flag link:
Excellent quarter from Teva, shares soar
Excellent quarter from Teva, shares soar
GoinPharma
Teva Pharmaceutical
earnings
Flag link:
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Flag link:
89Bio Joins NASH Chase with a Teva Drug and $60M in Funding
89Bio Joins NASH Chase with a Teva Drug and $60M in Funding
Xconomy
89Bio
Teva Pharmaceutical
NASH
Flag link:
Teva slumps after Express Scripts funds migraine rivals in US
Teva slumps after Express Scripts funds migraine rivals in US
Pharmaforum
PBMs
Teva Pharmaceutical
migraines
Ajovy
Express Scripts
Eli Lilly
Amgen
Flag link:
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Flag link:
Mylan's generic Copaxone wins in court, but market barriers remain
Mylan's generic Copaxone wins in court, but market barriers remain
Biopharma Dive
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
Flag link:

Pages